Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
References (0)
Cited by (247)
Current and future biomarkers in gastric cancer
2018, Biomedicine and PharmacotherapyCan β-catenin, Tenascin and Fascin be potential biomarkers for personalized therapy in Gastric carcinoma?
2023, Journal of Immunoassay and ImmunochemistryActivation of Laminin γ2 by Helicobacter pylori Promotes Invasion and Survival of Gastric Cancer Cells with E-Cadherin Defects
2022, Journal of Infectious DiseasesE-cadherin Expression in Canine Gastric Carcinomas: Association with Clinicopathological Parameters
2022, Veterinary SciencesFunctional Regulation Between Matrix Metalloproteases and Cell Junction Proteins in Gastric Cancer
2022, Handbook of Oxidative Stress in Cancer: Mechanistic AspectsPrognostic significance of e-cadherin, β-catenin and cyclin D1 in oral squamous cell carcinoma: A tissue microarray study
2021, Histology and Histopathology
Copyright © 1997 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.